Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

(2014) Raphaèle Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid arthritis medications and lactation

(2014) Lisa R. Sammaritano et al.   CURRENT OPINION IN RHEUMATOLOGY

Chloroquine Differentially Modulates Inflammatory Cytokine Expression in RAW 264.7 Cells in Response to Inactivated Staphylococcus aureus

(2014) Dan Zhou et al.   INFLAMMATION

Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome

(2014) Jacques-Eric Gottenberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Outcome measures for primary Sjögren's syndrome: A comprehensive review

(2014) Raphaèle Seror et al.   JOURNAL OF AUTOIMMUNITY

Hydroxychloroquine’s Efficacy as an Antiplatelet Agent Study in Healthy Volunteers

(2014) S. Achuthan et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation

(2014) Tamima Ashraf et al.   Journal of Neuroinflammation

Effect of Hydroxychloroquine on the Lipid Profile of Patients with Sjogren Syndrome

(2014) M. P. Migkos et al.   JOURNAL OF RHEUMATOLOGY

Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study

(2014) Gianantonio Saviola et al.   Modern Rheumatology

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial

(2014) Jacqueline Detert et al.   Trials

A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role

(2014) Mirella P. Hage et al.   Therapeutic Advances in Endocrinology and Metabolism

Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity

(2013) M E Doorenspleet et al.   ANNALS OF THE RHEUMATIC DISEASES

Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity

(2013) Lucía Martínez-Costa et al.   CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus

(2013) S. J. Carmichael et al.   INTERNAL MEDICINE JOURNAL

Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment

(2013) Cristen B. Chafin et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial

(2013) Sarah R Kingsbury et al.   Trials

Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issue

(2012) Claudio Vitali et al.   ANNALS OF THE RHEUMATIC DISEASES

Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus Cohort

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action

(2012) Catherine Mullié et al.   MALARIA JOURNAL

Conjunctival nodule in rheumatoid arthritis

(2012) Ahmad Kheirkhah et al.   INTERNATIONAL OPHTHALMOLOGY

Hydroxychloroquine: From Malaria to Autoimmunity

(2011) Ilan Ben-Zvi et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action

(2011) Steven J Katz et al.   CURRENT OPINION IN RHEUMATOLOGY

Pharmacogenetics: implications for therapy in rheumatic diseases

(2011) Lesley Davila et al.   Nature Reviews Rheumatology

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine

(2010) P. M. Izmirly et al.   ANNALS OF THE RHEUMATIC DISEASES

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

(2010) Hyejung Jung et al.   ARTHRITIS AND RHEUMATISM

Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness

(2010) R. B. M. LANDEWE et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis

(2010) F. R. BRENNAN et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Retina in rheumatic diseases: Standard full field and multifocal electroretinography in hydroxychloroquine retinal dysfunction

(2010) Marcella Nebbioso et al.   Clinical and Experimental Optometry

Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus

(2010) S. K. PENN et al.   JOURNAL OF RHEUMATOLOGY

Treatment Approaches to Juvenile Dermatomyositis (JDM) Across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey

(2010) E. STRINGER et al.   JOURNAL OF RHEUMATOLOGY

Towards evidence-based treatment of thrombotic antiphospholipid syndrome

(2010) Rhwm Derksen et al.   LUPUS

Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjögren patients: a prospective sample study

(2010) Hulya Çankaya et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax

(2009) H.-S. Lim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort

(2009) Guillermo J. Pons-Estel et al.   ARTHRITIS AND RHEUMATISM

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists

(2009) Eric N. van Roon et al.   CLINICAL THERAPEUTICS

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

(2009) RF van Vollenhoven et al.   LANCET

The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe

(2009) R Cervera et al.   LUPUS

The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine

(2009) MR Namazi   LUPUS

Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation

(2009) I. T. Padol et al.   RHEUMATOLOGY

Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus

(2009) E. Descloux et al.   RHEUMATOLOGY

Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration

(2009) Kristin Andreas et al.   ARTHRITIS RESEARCH & THERAPY

Effect of Chloroquine on the Urinary Excretion of Ciprofloxacin

(2008) Cajetan E Ilo et al.   AMERICAN JOURNAL OF THERAPEUTICS

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis

(2008) W Katchamart et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

(2008) G Ruiz-Irastorza et al.   ANNALS OF THE RHEUMATIC DISEASES

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis

(2008) Frederick Wolfe et al.   ARTHRITIS AND RHEUMATISM

Blonde by prescription

(2008) Stephan Meller et al.   ARTHRITIS AND RHEUMATISM

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody- 2-glycoprotein I complexes to phospholipid bilayers

(2008) J. H. Rand et al.   BLOOD

Estimated 10-year cardiovascular risk in a British population: results of a national screening project

(2008) H. A. W. Neil et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Hydroxychloroquine: the cornerstone of lupus therapy

(2008) G Ruiz-Irastorza et al.   LUPUS

Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival

(2008) A Sisó et al.   LUPUS

Severe hydroxychloroquine myopathy

(2008) Hoda Abdel-Hamid et al.   MUSCLE & NERVE

Retinal toxicity secondary to Plaquenil therapy

(2008) Betty Hanna et al.   OPTOMETRY

Ocular Toxicity of Hydroxychloroquine

(2008) Rodney Tehrani et al.   Seminars in Ophthalmology

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients

(2007) T. Hereng et al.   LUPUS